2024
Journal - Research Article
Wade, E. M., Goodin, E. A., Morgan, T., Pereira, S., Woolley, A. G., Jenkins, Z. A., Daniel, P. B., & Robertson, S. P. (2024). The hinge-1 domain of Flna is not necessary for diverse physiological functions in mice. European Journal of Clinical Investigation. Advance online publication. doi: 10.1111/eci.14308
Gould, M. L., Downes, N. J., Woolley, A. G., Hussaini, H. M., Ratnayake, J. T., Ali, M. A., Friedlander, L. T., & Cooper, P. R. (2024). Harnessing the regenerative potential of purified bovine dental pulp and dentin extracellular matrices in a chitosan/alginate hydrogel. Macromolecular Bioscience. Advance online publication. doi: 10.1002/mabi.202400254
2023
Journal - Research Article
Wiles, A. K., Mehta, S., Millier, M., Woolley, A. G., Li, K., Parker, K., Kazantseva, M., Wilson, M., Young, K., Bowie, S., Ray, S., Slatter, T. L., Stamp, L. K., Hessian, P. A., & Braithwaite, A. W. (2023). Activated CD90/Thy-1 fibroblasts co-express the Δ133p53β isoform and are associated with highly inflamed rheumatoid arthritis. Arthritis Research & Therapy, 25, 62. doi: 10.1186/s13075-023-03040-8
2022
Journal - Research Article
Shields, N. J., Peyroux, E. M., Campbell, K., Mehta, S., Woolley, A. G., Counoupas, C., Neumann, S., & Young, S. L. (2022). Calpains released from necrotic tumor cells enhance antigen cross-presentation to activate CD8+ T cells in vitro. Journal of Immunology, 209(9), 1635-1651. doi: 10.4049/jimmunol.2100500
2021
Journal - Research Article
McDougall, L., Kueh, J. T. B., Ward, J., Tyndall, J. D. A., Woolley, A. G., Mehta, S., Stayner, C., Larsen, D. S., & Eccles, M. R. (2021). Chemical synthesis of the PAX protein inhibitor EG1 and its ability to slow the growth of human colorectal carcinoma cells. Frontiers in Oncology, 11, 709540. doi: 10.3389/fonc.2021.709540
2020
Journal - Research Article
Mehta, S., Algie, M., Al-Jabry, T., McKinney, C., Kannan, S., Verma, C. S., … Parker, K., Henderson, L., Gould, M. L., Bhatia, P., Harfoot, R., … Kleffmann, T., … Woolley, A. G., … Braithwaite, A. (2020). Critical role for cold shock protein YB-1 in cytokinesis. Cancers, 12, 2473. doi: 10.3390/cancers12092473
Mehta, S., McKinney, C., Algie, M., Verma, C. S., Kannan, S., Harfoot, R., … Gould, M. L., Parker, K., … Cunliffe, H. E., … Kleffmann, T., Braithwaite, A. W., & Woolley, A. G. (2020). Dephosphorylation of YB-1 is required for nuclear localisation during G2 phase of the cell cycle. Cancers, 12(2), 315. doi: 10.3390/cancers12020315
2018
Conference Contribution - Poster Presentation (not in published proceedings)
Mehta, S., Algie, M., Al Jabri, T., McKinney, C., Verma, C., Weini, M., … Henderson, L., Gould, M., Parker, K., Bhatia, P., Harfoot, R., Kleffmann, T., … Woolley, A., & Braithwaite, A. (2018, August). RSK mediated YB-1 phosphorylation: A key event required for completion of cytokinesis. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
2016
Journal - Research Article
Lasham, A., Mehta, S. Y., Fitzgerald, S. J., Woolley, A. G., Hearn, J. I., Hurley, D. G., Ruza, I., Algie, M., … Braithwaite, A. W., & Print, C. G. (2016). A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line. International Journal of Cancer, 139(5), 1157-1170. doi: 10.1002/ijc.30137
Roth, I., Campbell, H., Rubio, C., Vennin, C., Wilson, M., Wiles, A., Williams, G., Woolley, A., … Fleming, N., Baird, M., & Braithwaite, A. W. (2016). The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2. Oncogene, 35, 4981-4989. doi: 10.1038/onc.2016.45
Conference Contribution - Verbal presentation and other Conference outputs
Mehta, S., Lasham, A., Woolley, A., Algie, M., Al Jabry, T., Ma, W., Fleming, N., Young, K., Parker, K., … Braithwaite, A. (2016, August-September). Role of YB-1 in cell cycle. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.
2015
Journal - Research Article
Fleming, J. S., Ruza, I., Thompson, B. A., Lee, K.-F., & Woolley, A. G. (2015). Effects of BRCA1 knockdown on CYP19a1/aromatase and steroid receptor expression in ovarian and tubal cells. Journal of Molecular & Genetic Medicine, 9(4), 185. doi: 10.4172/1747-0862.1000185
2013
Journal - Research Article
Awasthi, A., Woolley, A. G., Lecomte, F. J., Hung, N., Baguley, B. C., Wilbanks, S. M., Jeffs, A. R., & Tyndall, J. D. A. (2013). Variable expression of GLIPR1 correlates with invasive potential in melanoma cells. Frontiers in Oncology, 3, 225. doi: 10.3389/fonc.2013.00225
Lasham, A., Print, C. G., Woolley, A. G., Dunn, S. E., & Braithwaite, A. W. (2013). YB-1: Oncoprotein, prognostic marker and therapeutic target? Biochemical Journal, 449, 11-23. doi: 10.1042/bj20121323
2012
Journal - Research Article
Lasham, A., Samuel, W., Cao, H., Patel, R., Mehta, R., Stern, J. L., … Woolley, A. G., … Black, M. A., Shelling, A. N., Print, C. G., & Braithwaite, A. W. (2012). YB-1, the E2F Pathway, and regulation of tumor cell growth. Journal of the National Cancer Institute, 104(2), 133-146. doi: 10.1093/jnci/djr512
Conference Contribution - Verbal presentation and other Conference outputs
Algie, M., Jeffs, A., Woolley, A., Kleffmann, T., & Braithwaite, A. (2012, August). Identification of binding partners of the oncoprotein Y-box binding protein (YBX1) in breast cancer cell-line. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
2011
Journal - Research Article
Woolley, A. G., Algie, M., Samuel, W., Harfoot, R., Wiles, A., Hung, N. A., … Royds, J. A., Perez, D., Yoon, H.-S., … Braithwaite, A. W. (2011). Prognostic association of YB-1 expression in breast cancers: A matter of antibody. PLoS ONE, 6(6), e20603. doi: 10.1371/journal.pone.0020603
Conference Contribution - Poster Presentation (not in published proceedings)
Fleming, J. S., Ruza, I., Lee, K.-F., & Woolley, A. (2011, September). Aromatase/CYP19 and steroid receptor expression in response to BRCA1 knockdown in MCF-7 breast cancer cells and reproductive tract epithelial cells. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Woolley, A. (2011, March). Prognostic association of YB-1 expression in breast cancers: A matter of antibody. Verbal presentation at the New Zealand/Singapore Cancer Symposium, Dunedin, New Zealand.
2010
Journal - Research Article
Cohen, S. B., Ma, W., Valova, V. A., Algie, M., Harfoot, R., Woolley, A. G., … Braithwaite, A. W. (2010). Genotoxic stress-induced nuclear localization of oncoprotein YB-1 in the absence of proteolytic processing. Oncogene, 29, 403-410. doi: 10.1038/onc.2009.321
Sheard, P. W., Bewick, G. S., Woolley, A. G., Shaw, J., Fisher, L., Fong, S. W., & Duxson, M. J. (2010). Investigation of neuromuscular abnormalities in neurotrophin-3-deficient mice. European Journal of Neuroscience, 31(1), 29-41. doi: 10.1111/j.1460-9568.2009.07032.x
2009
Journal - Research Article
Jeffs, A. R., Glover, A. C., Slobbe, L. J., Wang, L., He, S., Hazlett, J. A., Awasthi, A., Woolley, A. G., … Print, C. G., … Eccles, M. R. (2009). A gene expression signature of invasive potential in metastatic melanoma cells. PLoS ONE, 4(12), e8461. doi: 10.1371/journal.pone.0008461
2008
Journal - Research Article
Woolley, A. G., Tait, K. J., Hurren, B. J., Fisher, L., Sheard, P. W., & Duxson, M. J. (2008). Developmental loss of NT-3 in vivo results in reduced levels of myelin-specific proteins, a reduced extent of myelination and increased apoptosis of Schwann cells. GLIA, 56(3), 306-317. doi: 10.1002/glia.20614
Conference Contribution - Poster Presentation (not in published proceedings)
Jeffs, A., Glover, A., He, S., Woolley, A., Eccles, M., & Baguley, B. (2008, August-September). Gene expression signatures of invasion in melanoma. Poster session presented at the Queenstown Molecular Biology Meetings, Queenstown, New Zealand.
2007
Conference Contribution - Poster Presentation (not in published proceedings)
Woolley, A., Hazlett, J., Li, G., & Eccles, M. (2007, May). Is PAX8 involved in the regulation of cell proliferation in ovarian cancer? Poster session presented at the New Zealand Society for Oncology Conference, Dunedin, New Zealand.
Li, C., Jeffs, A., He, S., Woolley, A., & Eccles, M. (2007, May). Is there cooperation, interference, or no interaction at all between PAX genes in promoting tumorigenesis? Poster session presented at the New Zealand Society for Oncology Conference, Dunedin, New Zealand.
Glover, A., He, S., Ineson, J., Jeffs, A., Woolley, A., Marshall, E., … Eccles, M. (2007, May). The role of PAX3 in malignant melanoma. Poster session presented at the New Zealand Society for Oncology Conference, Dunedin, New Zealand.
Glover, A., He, S., Ineson, J., Jeffs, A., Woolley, A., Marshall, E., … Eccles, M. (2007, August). The role of PAX3 in malignant melanoma. Poster session presented at the Inaugural Queenstown Molecular Biology Cancer Satellite Meeting, Queenstown, New Zealand.
Woolley, A., Hazlett, J., Li, C., & Eccles, M. (2007, August). Is PAX8 involved in the regulation of cell proliferation in ovarian cancer? Poster session presented at the Inaugural Queenstown Molecular Biology Cancer Satellite Meeting, Queenstown, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Glover, A., He, S., Ineson, J., Jeffs, A., Woolley, A., Marshall, E., … Eccles, M. (2007, September). Expression profiling, characterisation, and the role of PAX3 in the NZM panel of metastatic melanoma cell lines. Verbal presentation at the Joint Meeting of the 10th Annual Microarray and Gene Expression Data Society (MGED) Meeting and the 7th Annual Australasian Microarray and Associated Technologies (AMATA) Conference, Brisbane, Australia.
2005
Journal - Research Article
Woolley, A. G., Sheard, P. W., & Duxson, M. J. (2005). Neurotrophin-3 null mutant mice display a postnatal motor neuropathy. European Journal of Neuroscience, 21, 2100-2110.
Conference Contribution - Published proceedings: Abstract
Tait, K. J., Woolley, A. G., & Duxson, M. J. (2005). Neurotrophin-3 loss in vivo does not affect myelination at birth, but reduces myelination at three weeks in mice. New Zealand Medical Journal, 118(1225). Retrieved from http://journal.nzma.org.nz/journal/118-1225/1740/content.pdf
Woolley, A. G., Tait, K. J., Fisher, L., Kirschner, D. A., & Duxson, M. J. (2005). Role of neurotrophin-3 in the regulation of peripheral myelination in vivo. Mechanisms of Development. 122(Suppl.), (pp. S113). [Abstract]
2003
Awarded Doctoral Degree
Woolley, A. G. (2003). Development and perinatal maintenance of the neuromuscular system in neurotrophin-3 null mutant mice (PhD). University of Otago, Dunedin, New Zealand. 312p.
2002
Conference Contribution - Published proceedings: Abstract
Woolley, A., Sheard, P. W., & Duxson, M. J. (2002). Effects of NT-3 deficit on mouse neuromuscular development. Proceedings of the Third (2002) Asia Pacific Symposium on Neural Regeneration. (pp. 64). [Abstract]
1999
Journal - Research Article
Woolley, A., Sheard, P. W., Dodds, K. G., & Duxson, M. J. (1999). Alpha motoneurons are present in normal numbers but with reduced soma size in neurotrophin-3 knockout mice. Neuroscience Letters, 272, 107-110.